4-hydroxydinaphtho[2,1 -d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide compound with (1R,2S)-1-(6-bromo-2-methoxyquinolin -3-yl)-4- (dimethylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol(1:1)
医药中间体 · — · —
医药中间体Confidentiality：公开
- INN / Generic Name
- 4-hydroxydinaphtho[2,1 -d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide compound with (1R,2S)-1-(6-bromo-2-methoxyquinolin -3-yl)-4- (dimethylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol(1:1)
- Dosage Form
- —
- Strength
- —
- Therapy Area
- Pharmaceutical Intermediates
- Indication
- API: Bedaquiline Fumarate
- Current Status
- 官方中间体目录（API: Bedaquiline Fumarate）
- GMP Certification
- —
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- FSO 供货（非注册物质）
- MOQ
- 询价
- Lead Time
- 询价
- Price Range
- 询价
Registrable Markets
Global
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price
- —